Mid Europa to sell Romanian provider Regina Maria for over €1bn 

Mid Europa Partners, a central and eastern Europe-focused PE investor, is selling Regina Maria, Romania’s second largest private health care provider by revenue, after almost a decade of ownership. Turkish group Acibadem is rumoured to be likely to bid, although the group would not confirm this to HBI.

HBI 2023: Managing your costs in challenging times

Rising costs from inflation, wages, and energy are indiscriminately hitting the health care sector and despite government support packages being pledged, the road ahead looks arduous. So how do providers control costs, and what are the strategies to keep costs at bay?

HBI 2023: The outpatient differential

For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.

Digital health booming in CEE

Digital health is booming in Central and Eastern Europe (CEE), boosted by several countries in the region introducing major policy initiatives to integrate telehealth solutions and digitise their health systems. CEE-based multinational law firm Kinstellar spells this out in its latest ‘Current eHealth trends in CEE and Turkey’ report.

Acibadem eyes up UK opportunities

IHH-owned Turkish hospital group Acibadem has opened a contact centre in the Harley Street medical area in the UK and has an eye on market opportunities. HBI speaks to an operator and an advisor to find out more.

UK warns off Turkey after deaths

The UK Foreign and Commonwealth Office (FCO) has issued a travel warning following the deaths of 22 British nationals who sought medical treatment in Turkey. The country has recently seen a tsunami of patients taking the trip due to a failing NHS in England and the promise of more affordable cosmetic surgeries. HBI speaks to three Turkey-based analysts to understand whether the safeguarding concerns are warranted and what impact the warnings could have on the medical tourism industry.

Find Us